MENU

GMRE Stock Tickeron detected bullish Stock Pattern: Head-and-Shoulders Bottom on April 02, 2025

A.I.dvisor
at Tickeron.com
Loading...
Head-and-Shoulders Bottom
GMRE - Global Medical REIT
Tickeron
Emerged: 04/02/25
Breakout: $8.78
Price: $8.72
Target price: $9.18
A.I.dvisor detected a bullish Head-and-Shoulders Bottom pattern for GMRE stock. This pattern was detected on April 02, 2025 . The odds of reaching the target price are 6. The Head-and-Shoulders Bottom pattern is formed when the price of a security creates a center trough (the inverted head, labeled 3) and the left and right inverted shoulders (1, 5). After reaching the lowest low (the Head, 3) the next low is shallower and the trend reverses course to the upside. Consider buying a security or a call option at the low once the pattern is confirmed, which is known as the breakout point. The pattern is confirmed when the price breaks above the Neckline (2,4).

GMRE in +0.69% Uptrend, advancing for three consecutive days on March 31, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where GMRE advanced for three days, in of 295 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on March 27, 2025. You may want to consider a long position or call options on GMRE as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 227 cases where GMRE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for GMRE moved out of overbought territory on March 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 57 cases where GMRE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GMRE turned negative on March 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GMRE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GMRE broke above its upper Bollinger Band on March 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GMRE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.114) is normal, around the industry mean (1.987). P/E Ratio (37.565) is within average values for comparable stocks, (62.654). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (7.058). Dividend Yield (0.097) settles around the average of (0.070) among similar stocks. P/S Ratio (4.019) is also within normal values, averaging (7.141).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GMRE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

View a ticker or compare two or three
GMRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups

Industry RealEstateInvestmentTrusts

Profile
Fundamentals
Details
Industry
Real Estate Investment Trusts
Address
7373 Wisconsin Avenue
Phone
+1 202 524-6851
Employees
26
Web
https://www.globalmedicalreit.com